Two-day Kerala Cancer Conclave 2025 concludes
THIRUVANANTHAPURAM: The Kerala Cancer Conclave 2025, organised by the Association of Medical and Pediatric Oncologists of Kerala (AMPOK), concluded in Thiruvananthapuram on Sunday.
The two-day event brought together over 200 experts from India and abroad for a series of high-impact discussions on pressing issues in oncology.
The conclave featured eight key sessions addressing the growing cancer burden in the state, with a focus on emerging trends, future strategies, and barriers to optimal care.
Topics included the role and misuse of media in cancer control, challenges in access and affordability, pharmaceutical industry practices, and policy-making for effective cancer management. Sessions also explored strengthening the cancer research ecosystem and the transformative potential of genomics and precision medicine.
One of the highlights of the event was the release of a cancer opinion survey, which offered valuable insights into the challenges and opportunities in cancer treatment in Kerala, drawing on statistical data from local cancer patients.
The event was inaugurated by Speaker A N Shamseer. Dr Suresh H Advani, considered as the father of cancer treatment in India, was the chief guest. Artist B D Dethan performed a live painting during the inaugural ceremony.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
AMPOK announces cancer research grant worth Rs 5 lakh
THIRUVANANTHAPURAM: The Association of Medical and Paediatric Oncologists of Kerala (AMPOK) announced a research grant of Rs 5 lakh for cancer research at the Kerala Cancer Conclave 2025, which concluded on Sunday. The announcement comes at a time when experts are raising concerns about the quality of cancer studies, which are crucial for the prevention and treatment of cancer in the state. According to data presented by Prashant Mathur, Director of the National Centre for Disease Informatics and Research (NCDIR), by 2030, cancer is expected to affect 45,813 women and 43,930 men in Kerala. Dr Boben Thomas, secretary of AMPOK, revealed that 'Kerala Cancer Conclave 2.0' would be held in the future, promising further advancements and collaborations in the fight against cancer. Over the course of two days, the conclave featured extensive discussions on eight key topics and four dedicated scientific sessions. More than 50 esteemed speakers, including leading oncologists, healthcare policymakers, researchers, and industry leaders from around the world, participated in the event. On the final day, Dr Shaji Kumar, the Mark and Judy Mullins Professor of Hematological Malignancies and Chair of the Myeloma and Amyloidosis Group at Mayo Clinic, discussed the next-generation tools for cancer treatment, including CAR-T cell therapy and bispecific antibodies. Additionally, renowned artist B D Dethan performed a live painting during the inaugural ceremony, and AMPOK acquired the artwork. The event featured the launch of a special souvenir magazine, 'Stories That Heal, Visions That Inspire,' a heartfelt collection of reflections and insights from over twenty esteemed oncologists of Kerala origin. The first copy was unveiled by the souvenir's editor, Dr Ashok S Komaranchath, and presented to the dignitaries.
New Indian Express
a day ago
- New Indian Express
Two-day Kerala Cancer Conclave 2025 concludes
THIRUVANANTHAPURAM: The Kerala Cancer Conclave 2025, organised by the Association of Medical and Pediatric Oncologists of Kerala (AMPOK), concluded in Thiruvananthapuram on Sunday. The two-day event brought together over 200 experts from India and abroad for a series of high-impact discussions on pressing issues in oncology. The conclave featured eight key sessions addressing the growing cancer burden in the state, with a focus on emerging trends, future strategies, and barriers to optimal care. Topics included the role and misuse of media in cancer control, challenges in access and affordability, pharmaceutical industry practices, and policy-making for effective cancer management. Sessions also explored strengthening the cancer research ecosystem and the transformative potential of genomics and precision medicine. One of the highlights of the event was the release of a cancer opinion survey, which offered valuable insights into the challenges and opportunities in cancer treatment in Kerala, drawing on statistical data from local cancer patients. The event was inaugurated by Speaker A N Shamseer. Dr Suresh H Advani, considered as the father of cancer treatment in India, was the chief guest. Artist B D Dethan performed a live painting during the inaugural ceremony.
Time of India
2 days ago
- Time of India
New study warns of rising cancer burden in Kerala
T'puram: A recent study presented at the Kerala Cancer Conclave 2025 reveals alarming cancer trends in the state, with Kerala reporting an average 88,460 cases annually-43,110 among males and 45,350 among females. The national average stands at 1.56 million cases, making Kerala's contribution significant at nearly 5.7% of India's total cancer burden. By 2030, projections indicate a further rise to 43,930 cases in men and 45,813 in women. The report presented by Prof Prashant Mathur, Director, ICMR-National Center for Disease Informatics and Research, Bengaluru, points to stark gender-based disparities in cancer prevalence. Among men, lung cancer leads at 14%, followed by oral cavity (10%), colorectal (10%), prostate (9%), and liver cancers (8%). For women, breast cancer dominates at 34%, with thyroid (11%), colorectal (9%), uterine (6%), and ovarian cancers (4%) following. Among males, the most common cancers were lung (14%), oral cavity (10%), colorectum (10%), prostate (9%), and Jliver (8%). In females, breast cancer accounted for a striking 34%, followed by thyroid (11%), colorectum (9%), corpus uteri (6%), and ovary (4%). Dr Mathur highlighted the rising prevalence of lung, prostate, and liver cancers in men, and breast and thyroid cancers in women. Liver cancer, in particular, continues to show a rapid increase across both genders over the past two decades. In terms of crude mortality rates in Kerala in 2024, lung cancer led among men at 28.9%, followed by liver (18.9%), prostate (11.2%), stomach (8.3%), and mouth (8.3%). For women, breast cancer had the highest crude mortality rate at 37.5%, followed by lung (8.3%), ovary (6.6%), thyroid (6.1%), and cervix uteri (5.2%). Lung cancer mortality among men in the state is 28.9%, while the national average is only 7.8%. For breast cancer in women, Kerala's mortality rate is 37.5%, far above the national average of 14.9%.
